New perspectives for hypertension management: progress in methodological and technological developments

Author:

Parati Gianfranco12ORCID,Goncalves Alexandra3,Soergel David4,Bruno Rosa Maria5,Caiani Enrico Gianluca6,Gerdts Eva7ORCID,Mahfoud Felix8ORCID,Mantovani Lorenzo9,McManus Richard J10,Santalucia Paola11,Kahan Thomas1213

Affiliation:

1. Department of Cardiovascular, Neural and Metabolic Sciences, Istituto Auxologico Italiano IRCCS, Ospedale San Luca , Piazzale Brescia 20, 20149 Milano , Italy

2. Department of Medicine and Surgery, University of Milano-Bicocca , Via Cadore 48, 20900 Monza (MB) , Italy

3. Strategy & Partnerships, Philips , Cambridge, MA 02141 , USA

4. Cardiovascular, Renal, and Metabolic Drug Development, Novartis , Basel, CH 4056 , Switzerland

5. Paris Cardiovascular Research Centre (PARCC-INSERM U970) & Université de Paris , Paris 75015 , France

6. Politecnico di Milano, Electronics, Information and Bioengineering Department, Institute of Electronics, Computer and Telecommunication Engineering (IEIIT), National Research Council of Italy (CNR) , Milan 20133 & 24-10129 , Italy

7. Department of Clinical Science, University of Bergen , Bergen NO-5020 , Norway

8. Department of Internal Medicine III, Cardiology, Angiology, Intensive Care Medicine, Saarland University Hospital , Homburg 66123 , Germany

9. Value-based Healthcare Unit, IRCCS MultiMedica Research Hospital, University of Milan , Milan , Italy

10. Nuffield Department of Primary Care Health Sciences, University of Oxford , Oxford OX2 6HD , UK

11. Italian Association Against Thrombosis and Cardiovascular Diseases (ALT Onlus) , Milan 20123 , Italy

12. Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet , Stockholm SE 182 88 , Sweden

13. Department of Cardiology, Danderyd University Hospital Corp , Stockholm SE 182 88 , Sweden

Abstract

Abstract Hypertension is the most common and preventable risk factor for cardiovascular disease (CVD), accounting for 20% of deaths worldwide. However, 2/3 of people with hypertension are undiagnosed, untreated, or under treated. A multi-pronged approach is needed to improve hypertension management. Elevated blood pressure (BP) in childhood is a predictor of hypertension and CVD in adulthood; therefore, screening and education programmes should start early and continue throughout the lifespan. Home BP monitoring can be used to engage patients and improve BP control rates. Progress in imaging technology allows for the detection of preclinical disease, which may help identify patients who are at greatest risk of CV events. There is a need to optimize the use of current BP control strategies including lifestyle modifications, antihypertensive agents, and devices. Reducing the complexity of pharmacological therapy using single-pill combinations can improve patient adherence and BP control and may reduce physician inertia. Other strategies that can improve patient adherence include education and reassurance to address misconceptions, engaging patients in management decisions, and using digital tools. Strategies to improve physician therapeutic inertia, such as reminders, education, physician–peer visits, and task-sharing may improve BP control rates. Digital health technologies, such as telemonitoring, wearables, and other mobile health platforms, are becoming frequently adopted tools in hypertension management, particularly those that have undergone regulatory approval. Finally, to fight the consequences of hypertension on a global scale, healthcare system approaches to cardiovascular risk factor management are needed. Government policies should promote routine BP screening, salt-, sugar-, and alcohol reduction programmes, encourage physical activity, and target obesity control.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Epidemiology

Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3